Brighton Collaboration
 | This article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
 Service Mark of the Brighton Collaboration Foundation | |
| Formation | 2000 |
|---|---|
| Type | NPO |
| Purpose | Safest, effective vaccines based on rigorous science To enhance the science of vaccine research by providing standardized, validated, and objective methods for continuous monitoring of safety profiles and by assessing benefit-risk ratios. These methods are, in turn, recognized and recommended for use by international regulatory and public health agencies.[1] |
| Headquarters | Basel, Switzerland |
Region served | Worldwide |
Official language | English |
| Leader | Jan Bonhoeffer, president |
| Website | brightoncollaboration.us |
The Brighton Collaboration (BC) is a non-profit global vaccine safety research network for health care professionals, named after the city in England where the idea was first formulated.
The Brighton Collaboration was launched in 2000, although the idea of the collaboration started one year earlier, following a presentation by Bob Chen at an international scientific vaccine conference in Brighton. In his talk, he stressed the need to improve vaccine safety monitoring by developing internationally accepted standards.[2]
References[]
- ^ "EVI and Brighton Collaboration Foundation (BCF) sign Memorandum of Understanding (MoU)". Archived from the original on 2011-10-31. Retrieved 2012-07-17.
- ^ Chen RT (1999). "Vaccine risks: real, perceived and unknown". Vaccine. 17 Suppl 3: S41-6. doi:10.1016/s0264-410x(99)00292-3. PMID 10559533.
External links[]
 | This Switzerland-related article is a stub. You can help Wikipedia by . |
Categories:
- Vaccination-related organizations
- Switzerland stubs